Position in TAK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$33,687
+$11,659 QoQ
Shares Held
1,819
+28.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ancora Advisors LLC holds $9,377,058 across 14 Drug Manufacturers - Specialty & Generic names. TAK ranks #4 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
49,499 | $5,851,276 | |
| 2 | EBS |
Emergent BioSolutions Inc.
|
409,267 | $3,396,915 | |
| 3 | HLN |
Haleon plc
|
4,555 | $45,595 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
1,819 | $33,687 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
899 | $21,513 | |
| 6 | VTRS |
Viatris Inc
|
1,313 | $17,738 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
10 | $5,929 | |
| 8 | PRGO |
PERRIGO Co plc
|
313 | $3,361 |
All Filings in TAK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,687 | 1,819 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,028 | 1,413 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,686 | 1,413 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,844 | 1,413 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||